Literature DB >> 23548639

Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling.

Julhash U Kazi1, Lars Rönnstrand.   

Abstract

The suppressor of cytokine signaling 2 (SOCS2) is a member of the SOCS family of E3 ubiquitin ligases. SOCS2 is known to regulate signal transduction by cytokine receptors and receptor tyrosine kinases. The receptor tyrosine kinase FLT3 is of importance for proliferation, survival and differentiation of hematopoietic cells and is frequently mutated in acute myeloid leukemia. We observed that SOCS2 associates with activated FLT3 through phosphotyrosine residues 589 and 919, and co-localizes with FLT3 in the cell membrane. SOCS2 increases FLT3 ubiquitination and accelerates receptor degradation in proteasomes. SOCS2 negatively regulates FLT3 signaling by blocking activation of Erk 1/2 and STAT5. Furthermore, SOCS2 expression leads to a decrease in FLT3-ITD-mediated cell proliferation and colony formation. Thus, we suggest that SOCS2 associates with activated FLT3 and negatively regulates the FLT3 signaling pathways.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23548639      PMCID: PMC5528470          DOI: 10.1016/j.molonc.2013.02.020

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  33 in total

1.  Src family kinases are involved in the differential signaling from two splice forms of c-Kit.

Authors:  Olexandr Voytyuk; Johan Lennartsson; Akira Mogi; Georgina Caruana; Sara Courtneidge; Leonie K Ashman; Lars Rönnstrand
Journal:  J Biol Chem       Date:  2003-01-02       Impact factor: 5.157

2.  Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.

Authors:  Andrew Mehle; Joao Goncalves; Mariana Santa-Marta; Mark McPike; Dana Gabuzda
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

3.  Identification of Y589 and Y599 in the juxtamembrane domain of Flt3 as ligand-induced autophosphorylation sites involved in binding of Src family kinases and the protein tyrosine phosphatase SHP2.

Authors:  Elke Heiss; Kristina Masson; Christina Sundberg; Malin Pedersen; Jianmin Sun; Susanne Bengtsson; Lars Rönnstrand
Journal:  Blood       Date:  2006-05-09       Impact factor: 22.113

4.  Lack of Socs2 expression causes the high-growth phenotype in mice.

Authors:  S Horvat; J F Medrano
Journal:  Genomics       Date:  2001-03-01       Impact factor: 5.736

5.  Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis.

Authors:  K Hansen; M Johnell; A Siegbahn; C Rorsman; U Engström; C Wernstedt; C H Heldin; L Rönnstrand
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

6.  Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase.

Authors:  Alex N Bullock; Judit E Debreczeni; Aled M Edwards; Michael Sundström; Stefan Knapp
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-04       Impact factor: 11.205

7.  Pim serine/threonine kinases regulate the stability of Socs-1 protein.

Authors:  X Peter Chen; Julie A Losman; Simone Cowan; Elizabeth Donahue; Scott Fay; Bao Q Vuong; Martijn C Nawijn; Danielle Capece; Victoria L Cohan; Paul Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 8.  FLT3: ITDoes matter in leukemia.

Authors:  M Levis; D Small
Journal:  Leukemia       Date:  2003-09       Impact factor: 11.528

9.  SOCS2: inhibitor of JAK2V617F-mediated signal transduction.

Authors:  H Quentmeier; R Geffers; E Jost; R A F Macleod; S Nagel; S Röhrs; J Romani; M Scherr; M Zaborski; H G Drexler
Journal:  Leukemia       Date:  2008-09-04       Impact factor: 11.528

10.  Anchoring of FLT3 in the endoplasmic reticulum alters signaling quality.

Authors:  Dirk Schmidt-Arras; Sylvia-Annette Böhmer; Sina Koch; Jörg P Müller; Lutz Blei; Hauke Cornils; Reinhard Bauer; Sridhar Korasikha; Christian Thiede; Frank-D Böhmer
Journal:  Blood       Date:  2009-02-09       Impact factor: 22.113

View more
  31 in total

1.  The basic helix-loop-helix (bHLH) proteins in breast cancer progression.

Authors:  Nuzhat N Kabir; Lars Rönnstrand; Julhash U Kazi
Journal:  Med Oncol       Date:  2013-07-23       Impact factor: 3.064

Review 2.  Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia.

Authors:  Julhash U Kazi; Nuzhat N Kabir; Lars Rönnstrand
Journal:  Med Oncol       Date:  2013-10-31       Impact factor: 3.064

Review 3.  The role of cullin proteins in gastric cancer.

Authors:  Peng Chen; Guo-Dong Yao
Journal:  Tumour Biol       Date:  2015-10-15

Review 4.  Grb10 is a dual regulator of receptor tyrosine kinase signaling.

Authors:  Nuzhat N Kabir; Julhash U Kazi
Journal:  Mol Biol Rep       Date:  2014-01-14       Impact factor: 2.316

5.  KIAA0317 regulates pulmonary inflammation through SOCS2 degradation.

Authors:  Travis B Lear; Alison C McKelvey; John W Evankovich; Shristi Rajbhandari; Tiffany A Coon; Sarah R Dunn; James D Londino; Bryan J McVerry; Yingze Zhang; Eleanor Valenzi; Christine L Burton; Rachael Gordon; Sebastien Gingras; Karina C Lockwood; Michael J Jurczak; Robert Lafyatis; Mark J Shlomchik; Yuan Liu; Bill B Chen
Journal:  JCI Insight       Date:  2019-10-03

6.  Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling.

Authors:  Julhash U Kazi; Lars Rönnstrand
Journal:  Mol Oncol       Date:  2013-03-19       Impact factor: 6.603

Review 7.  FLT3-ITD and its current role in acute myeloid leukaemia.

Authors:  Francisco Alejandro Lagunas-Rangel; Venice Chávez-Valencia
Journal:  Med Oncol       Date:  2017-05-03       Impact factor: 3.064

8.  High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

Authors:  George S Laszlo; Rhonda E Ries; Chelsea J Gudgeon; Kimberly H Harrington; Todd A Alonzo; Robert B Gerbing; Susana C Raimondi; Betsy A Hirsch; Alan S Gamis; Soheil Meshinchi; Roland B Walter
Journal:  Leuk Lymphoma       Date:  2014-03-24

9.  The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.

Authors:  Meiling Cui; Ji Sun; Jianjing Hou; Tao Fang; Xin Wang; Chao Ge; Fangyu Zhao; Taoyang Chen; Haiyang Xie; Ying Cui; Ming Yao; Jinjun Li; Hong Li
Journal:  Tumour Biol       Date:  2016-07-28

Review 10.  SOCS6 is a selective suppressor of receptor tyrosine kinase signaling.

Authors:  Nuzhat N Kabir; Jianmin Sun; Lars Rönnstrand; Julhash U Kazi
Journal:  Tumour Biol       Date:  2014-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.